Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Other(3)

Detailed Status

unknown3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed125%
unknown375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

NCT03211351
unknownnot_applicable

Sjögren's Syndrome Is Associated With Meibomian Gland Dysfunction

NCT03434106
unknownnot_applicable

Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ?

NCT03060005
unknownnot_applicable

Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

NCT02992392

Clinical Trials (4)

Showing 4 of 4 trials
NCT03211351Not Applicable

Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

Completed
NCT03434106Not Applicable

Sjögren's Syndrome Is Associated With Meibomian Gland Dysfunction

Unknown
NCT03060005Not Applicable

Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ?

Unknown
NCT02992392Not Applicable

Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4